+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum cholinesterase activity in the diagnosis of nonalcoholic fatty liver disease in type 2 diabetic patients



Serum cholinesterase activity in the diagnosis of nonalcoholic fatty liver disease in type 2 diabetic patients



Pathophysiology 17(1): 29-32



The aim of the study was to compare the serum cholinesterase activities of a group of type 2 diabetic patients showing clinical evidence of nonalcoholic fatty liver disease to those of age and sex-matched type 2 diabetics who showed no evidence of liver disease, and healthy control subjects to determine, if serum cholinesterase can be used to diagnose nonalcoholic fatty liver disease in type 2 diabetic patients. Mean serum cholinesterase activity in diabetics with nonalcoholic fatty liver disease was found to be statistically significantly lower than in diabetics without liver disease and in healthy subjects. There was no statistically significant difference between the mean values of serum cholinesterase activities of non-liver disease diabetics and healthy control subjects. It was found that serum cholinesterase activity of 1640IU/L or less differentiated type 2 diabetic subjects with nonalcoholic fatty liver disease from diabetic subjects who were free of liver disease with a diagnostic sensitivity of 87.5% and specificity of 75%. It is suggested that routine monitoring of serum cholinesterase activities from the time of diagnosis of type 2 diabetes mellitus may reveal the earliest time for the change in serum cholinesterase activities in diabetics that signals the onset of nonalcoholic fatty liver disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055730126

Download citation: RISBibTeXText

PMID: 19540737

DOI: 10.1016/j.pathophys.2009.05.003


Related references

Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease. World Journal of Hepatology 7(25): 2610-2618, 2015

Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care 32(1): 147-152, 2009

Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Clinical Endocrinology 80(6): 877-883, 2014

Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients. Journal of Diabetes Research 2016: 3805372, 2016

Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients. Hepatobiliary and Pancreatic Diseases International 4(3): 389-392, 2005

Diabetic status and grade of nonalcoholic fatty liver disease are associated with lower baroreceptor sensitivity in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology and Hepatology 29(8): 956-961, 2017

Serum hepassocin concentrations in diabetic patients with or without nonalcoholic fatty liver disease. Diabetes Management 4(3): 255-261, 2014

Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients. Wiener Klinische Wochenschrift 126(11-12): 335-340, 2014

Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Gastroenterology and Hepatology 29(9): 1031-1035, 2017

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30(9): E94; Author Reply E95, 2007

Nonalcoholic fatty liver disease--a risk factor for microalbuminuria in type 2 diabetic patients. Romanian Journal of Internal Medicine 47(1): 55-59, 2009

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients: response to Targher et al. and Hu et al. Diabetes Care 30(6): E55; Author Reply E56-E55; Author Reply E56, 2007

LP52 : Nonalcoholic fatty liver disease (NAFLD) as potential risk factor of cardiovascular disease and oncological disease in diabetic type 2 patients. Journal of Hepatology 62: S288-S289, 2015

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54(12): 3541-3546, 2005

Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2:. Journal of Diabetes 7(2): 279-286, 2015